chr11-2445442-A-G
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The NM_000218.3(KCNQ1):c.344A>G(p.Glu115Gly) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E115K) has been classified as Pathogenic.
Frequency
Consequence
NM_000218.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNQ1 | NM_000218.3 | c.344A>G | p.Glu115Gly | missense_variant | Exon 1 of 16 | ENST00000155840.12 | NP_000209.2 | |
KCNQ1 | NM_001406836.1 | c.344A>G | p.Glu115Gly | missense_variant | Exon 1 of 15 | NP_001393765.1 | ||
KCNQ1 | NM_001406838.1 | c.344A>G | p.Glu115Gly | missense_variant | Exon 1 of 11 | NP_001393767.1 | ||
KCNQ1 | NM_001406837.1 | c.-19A>G | 5_prime_UTR_variant | Exon 1 of 17 | NP_001393766.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNQ1 | ENST00000155840.12 | c.344A>G | p.Glu115Gly | missense_variant | Exon 1 of 16 | 1 | NM_000218.3 | ENSP00000155840.2 | ||
KCNQ1 | ENST00000345015.4 | n.121A>G | non_coding_transcript_exon_variant | Exon 1 of 3 | 1 | |||||
KCNQ1 | ENST00000496887.7 | c.83A>G | p.Glu28Gly | missense_variant | Exon 2 of 16 | 5 | ENSP00000434560.2 | |||
KCNQ1 | ENST00000646564.2 | c.344A>G | p.Glu115Gly | missense_variant | Exon 1 of 11 | ENSP00000495806.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Identified in a patient referred for LQTS in published literature (PMID: 15840476); Functional studies demonstrate that this variant is folding-defective and results in trafficking defects and significantly reduced channel function (PMID: 30571187, 29532034); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 19862833, 17053194, 22581653, 36339618, 35442947, 29532034, 32960579, 30571187, 15840476) -
Long QT syndrome Pathogenic:1
This sequence change replaces glutamic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 115 of the KCNQ1 protein (p.Glu115Gly). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with clinical features of long QT syndrome (PMID: 15840476; Invitae). ClinVar contains an entry for this variant (Variation ID: 53037). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt KCNQ1 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects KCNQ1 function (PMID: 29532034, 30571187). This variant disrupts the p.Glu115 amino acid residue in KCNQ1. Other variant(s) that disrupt this residue have been observed in individuals with KCNQ1-related conditions (Invitae), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic. -
Cardiovascular phenotype Pathogenic:1
The p.E115G variant (also known as c.344A>G), located in coding exon 1 of the KCNQ1 gene, results from an A to G substitution at nucleotide position 344. The glutamic acid at codon 115 is replaced by glycine, an amino acid with similar properties. This alteration has been reported in a long QT syndrome (LQTS) cohort with limited clinical information (Tester DJ et al. Heart Rhythm. 2005;2:507-17). In vitro functional analysis suggests this variant results in significantly reduced channel current and a dominant negative trafficking defect (Huang H et al. Sci Adv. 2018;4:eaar2631). Internal structural analysis indicates that this variant interacts with residues of known function and is more disruptive than known pathogenic variants in the region (Ambry internal data; Berman HM et al. Acta Crystallogr. D Biol. Crystallogr. 2002;58:899-907). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
Congenital long QT syndrome Other:1
This variant has been reported as associated with Long QT syndrome in the following publications (PMID:15840476). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at